Table 1.

Estimated Economic Impact of DMPA due to Increased Prevalence of HIV Infection.

Women with HIV	255,900
Sexual transmission	87 percent
Cases due to sexual transmission	222,633
Ever use of DMPA	16.80 percent
Women with HIV with DMPA use	37,402
Relative risk (95 percent confidence interval) of HIV with DMPA use	1.4 (1.16–1.69)
Adjusted estimate	26,716
Excess cases	10,686
Highest estimated individual annual costs	US$53,664
Lowest estimated individual annual costs	US$14,712
Highest estimated total annual costs	US$573,474,111
Lowest estimated total annual costs	US$157,218,081